Sort
10,766 grants matching “checkpoint inhibitor”
Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling
$2,838,737Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Metabolic Regulation by SAPS3 of Virus-specific T cell Immunity
$2,832,747Roberto Tinoco · University Of California-Irvine · R01 · FY2025 · AI
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
$2,810,976E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA
Structural Cell Biology of DNA Repair Machines
$2,808,109John A Tainer · University Of Calif-Lawrenc Berkeley Lab · P01 · FY2013 · CA
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
$2,801,934E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2022 · CA
Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment
$2,800,993David E Fisher · Massachusetts General Hospital · P01 · FY2024 · CA
Immune Modulation After Allogeneic HCT
$2,779,234Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Consolidated Basic Cancer Research Program
$2,749,311Dario C. Altieri · Wistar Institute · P30 · FY2019 · CA
Immune Modulation After Allogeneic HCT
$2,740,234Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Immune Modulation After Allogeneic HCT
$2,739,426Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment
$2,734,241David E Fisher · Massachusetts General Hospital · P01 · FY2025 · CA
Genes and signals controlling mammalian hematopoiesis.
$2,727,753Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Consolidated Basic Cancer Research Program
$2,719,954Dario C. Altieri · Wistar Institute · P30 · FY2020 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2023 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2022 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2021 · CA
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$2,702,613James R. Heath · Institute For Systems Biology · U54 · FY2022 · CA
Immune Modulation After Allogeneic HCT
$2,684,637Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2022 · CA
Immune Modulation After Allogeneic HCT
$2,684,637Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2023 · CA
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
$2,680,832E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2024 · CA
ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular carcinoma (ELEVATE)
$2,678,459Devanand Sarkar · Virginia Commonwealth University · P01 · FY2024 · CA
ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular carcinoma (ELEVATE)
$2,646,688Devanand Sarkar · Virginia Commonwealth University · P01 · FY2025 · CA
Vaccine strategies for HIVAIDS
$2,640,125Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Role of GRAIL in B cell tolerance and B-cell mediated inflammation
$2,630,572Roza Insafetdinovna Nurieva · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · AI
Combination Therapies to Defeat Melanoma Resistance
$2,608,967Antoni Ribas · University Of California Los Angeles · P01 · FY2021 · CA